Parliamentary panel asks if Bangladesh will take legal action against Serum Institute
Staff Correspondent, bdnews24.com
Published: 09 May 2021 09:07 PM BdST Updated: 09 May 2021 09:07 PM BdST
-
Bangladesh is using COVISHIELD, the vaccine developed by the UK’s University of Oxford and British-Swedish drug maker AstraZeneca, imported from the Serum Institute of India in the inoculation campaign. Photo: Mahmud Zaman Ovi
A parliamentary committee has asked the government to think about taking legal action against the Serum Institute of India for its failure to deliver coronavirus vaccine as per a deal.
The committee on the foreign ministry on Sunday discussed the vaccine crisis created by a shortage of enough doses to continue the mass immunisation drive.
Committee Chairman Muhammad Faruk Khan said they asked the ministry why the government did not follow the panel’s recommendation made in February to bring coronavirus vaccine from more than one source.
“The [foreign] ministry has explained that the matter depends on the health ministry. But they are trying to bring vaccine from multiple sources while hoping to get the doses from India,” he said.
After India halted export of the AstraZeneca vaccine, manufactured by the Serum Institute of India, due to its own crisis, Bangladesh stopped administering the first doses to save second doses for the people who have had the first dose.
But Bangladesh is already short of enough doses to fully vaccinate all the citizens who have received the first dose.
The government has fast-tracked the process to bring vaccines from Russia and China, but mixing the doses is still not a favourable option, meaning it needs to bring necessary AstraZeneca shots.
Bangladesh has recently requested the US to send four million doses of the AstraZeneca vaccine after the Joe Biden administration decided to share up to 60 million doses of the vaccine with other countries.
Khan said the committee asked the government to take quick steps to get the doses from the US and ensure unhindered second dosing.
“We’ve also asked them (ministry) to think whether they will take legal action against Serum Institute for not delivering the doses,” he added.
The ministry informed the committee that Bangladesh may get some doses from India in July.
The committee recommended strengthening border patrol to ensure that no one can enter Bangladesh from India unmonitored.
Bangladesh on Saturday decided to keep the land border shut for travellers from India for two more weeks over fears of coronavirus variant that is likely behind a devastating COVID-19 surge there.
-
How worried should
Bangladesh be
about Taliban?
-
We must repay debt
to Bangabandhu: PM
-
Govt officials to undergo dope tests: minister
-
11 bodies of missing
Rohingya recovered
-
Govt to bar Tazia procession in pandemic
-
Daily count: 198 virus
deaths, 7,535 cases
-
Woman gets trafficked to rescue daughter
-
Bangladeshis who joined Taliban will be arrested: DMP
-
How worried should Bangladesh be about the Taliban takeover of Afghanistan?
-
Bangladesh must repay its debt to Bangabandhu: Hasina
-
Govt officials to undergo drug test once a year: minister
-
11 bodies of Rohingya who attempted to flee from Bhasan Char recovered
-
Bangladesh to bar Tazia procession in pandemic
-
Bangladesh logs 198 virus deaths, 7,535 new cases in a day
Most Read
- Bangladesh to resume air bubble flights with India on Aug 20
- Bangladesh court orders 3-month ban on addictive online games PUBG, Free Fire
- What if you could become invisible to mosquitoes?
- As offices and public transport reopen, traffic jams return to Dhaka streets
- Taliban, striking dovish tone, promise peace and women's rights under Islam
- Taliban order fighters to respect foreigners in Afghanistan: official
- 50 injured as BNP activists and police clash at Chandrima Udyan
- Bangladesh logs 198 virus deaths, 7,535 new cases in a day
- Over 600 Afghans cram into US cargo plane in desperate flight from Kabul
- How worried should Bangladesh be about the Taliban takeover of Afghanistan?





